Phase Ib clinical and pharmacological study of multiple schedules of pazopanib (P) and epirubicin (EPI) in patients with advanced solid tumors.Angelica Fasolo, Luca Gianni, Gianluca Del Conte et al.|Journal of Clinical Oncology|2010Cited by 1